BriaCell Therapeutics's total assets for Q1 2025 were $10.41M, an increase of 77.35% from the previous quarter. TSE:BCT total liabilities were $6.70M for the fiscal quarter, a -21.69% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.